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Abstract 
 
Retinitis pigmentosa (RP) is a clinically and genetically heterogeneous form of 
retinal degeneration. Several genes and loci have been shown to be involved in the 
disease, although each of them could only account for a few cases. Mutations in the 
gene encoding ROM1, a rod-specific protein, have been putatively associated with 
several forms of RP. Here we describe a double mutant allele of this gene, P60T and 
T108M, present in two affected sibs and also in two healthy members of a Spanish 
RP family. The same double mutant allele was previously considered to be 
responsible for autosomal dominant RP in one family. We now report data that 
questions the potential pathogenicity of these two ROM1 mutations. 
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Introduction 
 
Retinitis Pigmentosa (RP) is a group of inherited retinal disorders characterized by a 
progressive constriction of peripheral visual fields, night blindness and, eventually, 
severe visual impairment (Heckenlively et al. 1988). Both linkage analysis and the 
candidate gene approach have identified several RP genes and loci (Dryja and Li 
1995), but the genetic defect in most cases remains unknown. 
 One such gene is that encoding the rod outer segment membrane protein 
(ROM1) (Kajiwara et al. 1994; Sakuma et al. 1995; Bascom et al. 1995). Its  product 
was first identified as a disk-rim protein, present in the rod outer segment and 
absent in cones (Bascom et al. 1992). However, recent experiments with anti-ROM1 
antibodies suggest that it could be present in both photoreceptor cells (Moritz and 
Molday 1996). 
 To identify the molecular defect underlying the disease in an RP family, eight 
candidate genes were analyzed. The two affected sibs bore a double mutant allele of 
ROM1, P60T and T108M. This allele has been described as the cause of RP in 
another family (Bascom et al. 1995). 
 
 
Materials and methods 
 
Pedigree and clinical evaluation 
 
The pedigree studied (referred to as V-8) comprises two branches with a total of 
three affected members (Fig.1). Clinical and electrophysiological studies (Table 1) 
included measurement of visual acuity, fundus examination, visual field testing, 
electroretinogram (ERG), electrooculogram (EOG) and dark adaptation. Ganzfeld 
ERGs were assessed, for both affected and non affected members of the family, 
according to the International Society for the Clinical Electrophysiology of Vision 
Standards (ISCEV). Rod-isolated responses were obtained under scotopic dark-
adapted (20 min) conditions, mixed cone-rod responses with single flashes of white 
light in scotopic conditions and cone-isolated responses with 30 Hz white flickering 
light in fotopic conditions. EOG testing was performed following the ISCEV 
protocol using a Ganzfeld stimulator and a Compact Four Ca-2000 computer 
(Nicolet). 
 Informed consent was obtained from all subjects after the nature and possible 
consequences of the study had been explained. 
 4 
 
 
Analysis of DNA polymorphisms 
 
Genomic DNA was extracted from peripheral blood according to Miller et al. (1988). 
 Microsatellite markers at β-subunit of rod phosphodiesterase (PDEB), 
rhodopsin (RHO) and recoverin (D17S786) genes were from the MapPairs set 
(Research Genetics, Huntsville, AL). The polymorphisms at the peripherin/RDS 
gene were as described elsewhere (Kumar-Singh et al. 1991; Bayés et al. 1996). Two 
internal variants, 1447A/G and 1683delC, were used for cosegregation analyses of 
the γ subunit of rod phosphodiesterase (PDEG) (Hahn et al. 1994). Finally, 
cosegregation with S antigen (SAG) was studied using an intragenic tri-allelic 
polymorphism (Sheffield et al. 1992), detected by ASO hybridization. 
 PCR conditions were as follows: genomic DNA (300 ng) was amplified in a 25 
µl reaction mixture containing 6.6 pmols of each primer, 1 unit of Dynazyme DNA 
polymerase (Fynzymes Oy, Espoo, Finland) in the recommended buffer and 200 µM 
dNTPs. The PCR amplification profile was: 94oC 40 s, 50-60oC 30 s (x35); 72oC 5 min 
(x1). 
 
 
Mutation analysis 
 
A PCR-SSCP strategy was used for mutation screening. Oligonucleotide primers 
flanking the coding regions of PDEG, peripherin/RDS and ROM1 genes, were 
designed according to the published genomic sequences (Piriev et al. 1994; Travis et 
al. 1991; Bascom et al. 1993a). For Neural Retinal Leucine Zipper (NRL) gene, 
primers were kindly provided by Dr. A. Swaroop. Oligonucleotides to amplify the 
coding regions of PDEB and RHO were as described elsewhere (Riess et al. 1992; 
Keen et al. 1991). 
 PCR conditions were as described above except for a final reaction volume of 
50 µl. 
 The protocol for SSCP analysis has been published elsewhere (Bayés et al. 
1995). All samples were run under three sets of conditions, varying acrylamide and 
glycerol concentrations and running temperatures. 
 
 
DNA sequencing 
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PCR products giving an aberrant SSCP pattern were purified by the QIAquick-spin 
PCR Purification Kit (Qiagen Inc, Chatsworth, USA) and cloned into pUC18 using 
the Sure CloneTM Ligation Kit (Pharmacia Biotech, Uppsala, Sweden). Three to five 
mutant clones were sequenced in each case by the dideoxy chain-termination 
method using the T7 sequencingTM Kit (Pharmacia). When the variant identified 
altered the recognition site for a restriction enzyme, PCR products were further 
digested with the corresponding enzyme to confirm the nucleotide change. 
 
 
Results and Discussion 
 
The pattern of inheritance of RP in family V-8 (Fig.1) is unclear. Individuals I.1 and 
I.2 are descendants from a consanguineous marriage and members I.2 and I.3 come 
from the same small village. These data suggest a recessive pattern of inheritance. 
However, the presence of affected individuals in two generations (three females), 
would favour the hypothesis of RP segregating as a dominant trait. If this is the case, 
incomplete penetrance would have to be assumed. Heterogeneity in phenotypic 
expression due to incomplete penetrance has already been documented in ADRP 
families (Berson and Simonoff 1979; Kim et al. 1994). 
 Clinical and electrophysiological data of the available affected and healthy 
members are shown in Table 1. The probands, individuals II.4 and II.5, present a 
typical form of RP. According to clinical records, individual I.1 had also been 
diagnosed as affected of RP. Individual I.2, the mother of the probands, showed 
decreased values of visual acuity and ERGs, which could be attributable to both 
cataracts and age, while her fundus examination appeared totally normal. The 
clinical parameters of the remaining members examined were all comprised within 
the normal ranges, although there was a high degree of variability for the ERG 
values. Individuals III.1, III.3 and III.4 were healthy at the time of the study but, 
considering the age of onset of RP in their mothers, they were still too young to be 
diagnosed with certainty. Finally, individuals II.1, II.2 and II.3 denied having any 
visual impairment. 
 The involvement in the disease of the PDEB, PDEG, peripherin/RDS, 
recoverin, RHO, NRL, SAG and ROM1 genes was assessed by combining 
cosegregation and mutation analyses. Four aberrant SSCP patterns were detected, 
corresponding to PCR fragments of exon 22 of PDEB, exon 3 of NRL and exons 1 
and 2 of ROM1. Cloning and sequencing of the PDEB  fragment revealed a known 
polymorphism, 2598G/A (Collins et al. 1992). Moreover, analysis of exon 3 of NRL 
identified a novel silent nucleotide substitution, 4723C/T. 
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 The third aberrant SSCP pattern revealed a ROM1 allele with two nucleotide 
changes, each leading to an amino acid substitution, P60T and T108M. This double 
mutant allele is identical to that described by Bascom et al. (1995) in only the 
affected members of a small ADRP family. However, in V-8 the ROM1 allele is 
present in all the affected individuals as well as in some healthy members (Fig.1). To 
exclude minimal functional disturbances in some of these subjectively healthy 
carriers, individuals I.2, II.3 and II.6 were subjected to EOG and dark adaptation 
tests. Individual I.2 (aged 72) showed an EOG Arden ratio of 150 (normal values are 
above 180; see Table 1), and the rod threshold of the dark adaptation curve was 
slightly increased. However, these results could be attributable, again, to both 
cataracts and age. Individuals II.3 and II.6 showed EOG ratios of 200 and their dark 
adaptation curves were normal.   
 Finally, analysis of the fourth aberrant SSCP pattern, corresponding to exon 2 
of ROM1, identified the 1071G/C polymorphism (Bascom et al. 1993b) and a 
segregation study showed that the two affected sisters had inherited different 
paternal alleles (Fig. 1). Taking these data together, the involvement of the ROM1 
gene in a recessive form of the disease is ruled out in this family.  
 Kajiwara et al. (1994) reported a digenic form of RP in three families due to 
mutations in ROM1 and RDS genes. To test this model, we analyzed the 
peripherin/RDS internal polymorphisms 558C/T and 1294C/T in our family, which 
showed that the affected sibs did not share the paternal peripherin/RDS allele. 
Thus, the hypothesis of a digenic ROM1/RDS pattern of inheritance is ruled out. 
 The role of the ROM1 double mutant allele in RP is still unclear. 
Nevertheless, in family V8 there is a correlation between its presence and abnormal 
or low ERG values. Unaffected individuals bearing this allele showed the lowest 
ERG recordings (see Table 1). Additionally, the mutant allele has been only 
described in another RP family but not found in the 200 control chromosomes 
analyzed by Bascom et al. (1995), nor in a sample of 76 chromosomes studied here. 
 The mutant ROM1 allele could be directly involved in the disease as a 
dominant mutation with incomplete penetrance or highly variable expressivity. 
Some ADRP families showing highly heterogeneous phenotypic expression have 
been reported recently (Kim et al. 1995; Evans et al. 1995; Xu et al. 1995). 
Alternatively, a digenic pattern involving ROM1 and another unidentified gene 
could be considered. Indeed, according to Bascom et al. (1992) a ROM1-
peripherin/RDS complex of four subunits would associate with other proteins in 
rods. Alterations in any of these unknown proteins together with mutations in 
ROM1 could help explain this case of RP. However, in the absence of conclusive 
data, the pathogenicity of this mutant ROM1 allele is questionable. 
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Fig.1. Pedigree of family V-8 showing ROM1 and peripherin/RDS haplotypes. 
Arrows indicate the peripherin/RDS alleles inherited from the father in the two 
affected sisters. Members whose DNA was not available are marked with an 
asterisk. 
 
 
Table 1. Results of the ophthalmologic test in family V-8. 
 
 
Patient 
 
 
Age 
 
Age at 
onset 
 
 
Visual 
acuity1 
 
 
Fundus2 
 
Visual  
field3 
 
ERGR1,4 
 
ERGC1,5 
 
ERGCR1,6 
 
EOG7 
 
 
I.2 
 
 
72 
 
- 
 
OD-0.4 
OS-0.6 
 
NORMAL 
 
NORMAL 
 
OD-133 
OS-106 
 
OD-49 
OS-47 
 
OD-240 
OS-204 
 
<150 
 
II.3 
 
 
- 
 
- 
 
OD- 
OS- 
 
- 
 
- 
 
OD- 
OS- 
 
OD- 
OS- 
 
OD- 
OS- 
 
200 
 
II.4 
 
47 
 
30 
 
OD-0.7 
OS-0.1 
 
RP-D 
 
TV 
 
OD-30 
OS-27 
 
OD-0 
OS-0 
 
OD-43 
OS-43 
 
- 
 
II.5 
 
45 
 
30 
 
OD-FC 
OS-FC 
 
RP-D 
 
TV 
 
OD-0 
OS-0 
 
OD-8 
OS-7 
 
OD-9 
OS-8 
 
- 
 
II.6 
 
39 
 
- 
 
OD-1 
OS-1 
 
NORMAL 
 
NORMAL 
 
OD-156 
OS-160 
 
OD-48 
OS-53 
 
OD-256 
OS-270 
 
200 
 
II.7 
 
 
34 
-  
OD-1 
OS-1 
 
NORMAL 
 
NORMAL 
 
OD-247 
OS-238 
 
OD-78 
OS-77 
 
OD-396 
OS-388 
 
- 
 
III.1 
 
 
25 
-  
OD-1 
OS-1 
 
NORMAL 
 
NORMAL 
 
OD-282 
OS-277 
 
OD-103 
OS-95 
 
OD-419 
OS-398 
 
- 
 
III.3 
 
 
18 
-  
OD-1 
OS-1 
 
NORMAL 
 
NORMAL 
 
OD-179 
OS-208 
 
OD-72 
OS-71 
 
OD-354 
OS-376 
 
- 
 
III.4 
 
 
16 
-  
OD-1 
OS-1 
 
 
NORMAL 
 
NORMAL 
 
OD-174 
OS-183 
 
OD-97 
OS-90 
 
OD-317 
OS-318 
 
- 
 
 
1. OD: right eye; OS: left eye; FC: finger count; 2. RP-D: diffuse RP; 3. TV: tunnel vision; 4. Rod function, lower normal limit 100 
micro-volt; 5. Cone function, lower normal limit 50 micro-volt; 6. Cone and rod function, lower normal limit 150 micro-volt; 7. EOG 
Arden ratio, lower normal limit 180. 
 

